As drug discovery demands greater speed and accuracy, advances in automation are transforming high-throughput screening. Rob ...
Forbes Agency Council Member Joel House Challenges the $16B AI Industry With a Revenue-First Framework Santa Monica, ...
In this interview, James Atwood, CEO of Opentrons, discusses the tasks most ripe for automation today, what “autonomous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results